Rectal MRI radiomics for predicting pathological complete response: Where we are
- 16 November 2021
- journal article
- research article
- Published by Elsevier in Clinical Imaging
- Vol. 82, 141-149
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30 CA008748)
- National Cancer Institute (R01CA233888)
This publication has 62 references indexed in Scilit:
- Texture Analysis as Imaging Biomarker of Tumoral Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients Studied with 3-T Magnetic ResonanceInvestigative Radiology, 2015
- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CJournal of Hepatology, 2013
- Distribution of Residual Cancer Cells in the Bowel Wall After Neoadjuvant Chemoradiation in Patients With Rectal CancerDiseases of the Colon & Rectum, 2013
- Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal CancerAnnals of Surgical Oncology, 2012
- Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY ExperienceJournal of Clinical Oncology, 2011
- Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?Colorectal Disease, 2011
- Anatomical Global Spatial NormalizationNeuroinformatics, 2010
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- CERR: A computational environment for radiotherapy researchMedical Physics, 2003